Status and phase
Conditions
Treatments
About
Administration of a nutritional supplement containing palmitoyethanolamide, alpha lipoic acid, vitamin B12, vitamin B6 , vitamin B1, nicotinamide, magnesium, zinc, vitamin E, and superoxide of dismutase in individuals receiving chemotherapy
Full description
Investigation of effectiveness and safety of a nutritional supplement containing palmitoyethanolamide, alpha lipoic acid, vitamin B12, vitamin B6 , vitamin B1, nicotinamide, magnesium, zinc, vitamin E, and superoxide of dismutase in individuals receiving chemotherapy
Enrollment
Sex
Volunteers
Inclusion criteria
Exclusion criteria
Not receiving dietary supplement
Have already neuropathy
Have already started chemotherapy
Patients with uncontrolled diabetes
-- Patients with chronic kidney disease
Patiens with recent cardiovascular incident
Primary purpose
Allocation
Interventional model
Masking
71 participants in 2 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal